[Federal Register Volume 66, Number 213 (Friday, November 2, 2001)]
[Notices]
[Page 55679]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-27520]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 01N-0336]


Schering Corp. et al.; Withdrawal of Approval of 51 New Drug 
Applications and 25 Abbreviated New Drug Applications; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY:  The Food and Drug Administration (FDA) is correcting a notice 
that appeared in the Federal Register of August 16, 2001 (66 FR 43017). 
The document announced the withdrawal of approval of 51 new drug 
applications (NDAs) and 25 abbreviated new drug applications (ANDAs). 
The document inadvertently withdrew approval of NDA 17-255 for DTPA 
(chelate) Multidose (kit for the preparation of Tc-99m pentetate 
injection) held by Nycomed Amersham Imaging, 101 Carnegie Center, 
Princeton, NJ 08540. FDA confirms that approval of NDA 17-255 is still 
in effect.

EFFECTIVE DATE:  August 16, 2001.

FOR FURTHER INFORMATION CONTACT: Florine P. Purdie, Center for Drug 
Evaluation and Research (HFD-7), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, 301-594-2041.
    In FR Doc. 01-20605 appearing on page 43017 in the Federal Register 
of Thursday, August 16, 2001, the following correction is made: On page 
43018, in the table, the entry for NDA 17-255 is removed.

    Dated: October 11, 2001.
Janet Woodcock,
Director, Center for Drug Evaluation and Research.
[FR Doc. 01-27520 Filed 11-01-01; 8:45 am]
BILLING CODE 4160-01-S